May 23, 2024
Persistent Smokers

Persistent Smokers More Likely to Quit with Customized Smoking-Cessation Treatment and Increased Medication Doses: New Study

A recent study published in The University of Texas MD Anderson Cancer Center sheds light on the effectiveness of customized smoking-cessation treatments for individuals who have previously failed in their attempts to quit. The research revealed that altering treatment regimens and increasing medication doses could significantly boost the chances of success for persistent smokers.

According to the study, most smokers find it challenging to quit on their initial attempt. However, the findings suggest that tailoring smoking-cessation treatments to individual needs and adjusting doses as required could make a substantial difference.

The researchers compared the efficacy of varenicline, a cessation medication, and combined nicotine replacement therapy (CNRT), which includes nicotine patches or lozenges. The results indicated that varenicline was more effective in helping smokers quit compared to CNRT.

The study’s lead author, Dr. Mustafa Sahin, stated, “Our findings suggest that a personalized approach to smoking cessation, including adjusting doses and treatment regimens, could significantly improve the chances of success for those who have previously struggled to quit.”

The research adds to the growing body of evidence supporting the importance of customized smoking-cessation treatments and the potential benefits of using more effective medications like varenicline. The study’s findings could pave the way for more personalized and effective smoking-cessation programs in the future.

The study highlights the importance of customized smoking-cessation treatments and the potential benefits of increasing medication doses and altering treatment regimens for persistent smokers. The findings also suggest that varenicline may be a more effective option compared to combined nicotine replacement therapy for individuals seeking to quit smoking.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research.
2. We have leveraged AI tools to mine information and compile it.